Drug intelligence / Profile preview

N-{(1S,2R)-1-benzyl-3-[(cyclopropylmethyl)(2-furylsulfonyl)amino]-2-hydroxypropyl}-N'-methylsuccinamide

Development stage: Unknown
Lead developer: Degussa
Modality: Small Molecules

Overview

This compound is an experimental small molecule with the chemical formula C23H31N3O6S and a molecular weight of approximately 477.57 g/mol. It belongs to the class of organic compounds known as phenylbutylamines. There are no approved indications or clinical trials reported for this molecule, and it is not currently approved for use in any country. Its mechanism of action, pharmacological activity, and therapeutic potential have not been described in publicly available sources[1][6].

Other names: N-{(1S,2R)-1-benzyl-3-[(cyclopropylmethyl)(2-furylsulfonyl)amino]-2-hydroxypropyl}-N'-methylsuccinamide

Beyond the preview

Go deeper on N-{(1S,2R)-1-benzyl-3-[(cyclopropylmethyl)(2-furylsulfonyl)amino]-2-hydroxypropyl}-N'-methylsuccinamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-{(1S,2R)-1-benzyl-3-[(cyclopropylmethyl)(2-furylsulfonyl)amino]-2-hydroxypropyl}-N'-methylsuccinamide.

Explore the full profile